Transcend Capital Advisors’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Buy
26,215
+1,038
+4% +$62.7K 0.11% 178
2026
Q1
$1.47M Buy
25,177
+10,901
+76% +$645K 0.12% 170
2025
Q4
$808K Buy
14,276
+3,370
+31% +$184K 0.06% 268
2025
Q3
$579K Buy
10,906
+2,898
+36% +$157K 0.04% 347
2025
Q2
$379K Buy
8,008
+2,893
+57% +$128K 0.03% 394
2025
Q1
$212K Sell
5,115
-827
-14% -$32.5K 0.02% 557
2024
Q4
$216K Buy
5,942
+212
+4% +$7.66K 0.02% 524
2024
Q3
$210K Buy
+5,730
New +$205K 0.01% 569
2022
Q2
– Sell
-5,306
Closed -$224K – 504
2022
Q1
$224K Buy
+5,306
New +$226K 0.02% 454

Other funds holding BTI

Transcend Capital Advisors's BTI Position: Q2 2026 in Review

Transcend Capital Advisors increased its British American Tobacco (BTI) stake by 4.1% in Q2 2026, buying an estimated $62.7K and bringing the position to 26,215 shares worth $1.62M. The position accounts for 0.11% of the portfolio, ranked #178.

Transcend Capital Advisors first reported a position in BTI in Q1 2022 and has held it in 9 quarters since. 910 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • Transcend Capital Advisors held 26,215 shares of British American Tobacco worth $1.62M as of Q2 2026.
  • Transcend Capital Advisors bought 1,038 British American Tobacco shares in Q2 2026, an estimated $62.7K.
  • British American Tobacco made up 0.11% of Transcend Capital Advisors's portfolio in Q2 2026, its #178 holding.
  • Transcend Capital Advisors first reported a position in British American Tobacco in Q1 2022 and has held it in 9 quarters since.
  • 910 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.